SINT 📈 SINTX Technologies - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8293923079
SINT: Medical Devices, Ceramic Materials, Nitride Powders, Coatings, Composite Materials
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. Web URL: https://www.sintx.com
Additional Sources for SINT Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SINT Stock Overview
| Market Cap in USD | 5m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 2014-02-13 |
SINT Stock Ratings
| Growth 5y | -96.0% |
| Fundamental | -3.09% |
| Dividend | - |
| Rel. Strength Industry | -5844 |
| Analysts | 3/5 |
| Fair Price Momentum | 4.22 USD |
| Fair Price DCF | - |
SINT Dividends
No Dividends PaidSINT Growth Ratios
| Growth Correlation 3m | 56.4% |
| Growth Correlation 12m | -89.8% |
| Growth Correlation 5y | -91.7% |
| CAGR 5y | -83.87% |
| CAGR/Mean DD 5y | -1.08 |
| Sharpe Ratio 12m | -0.38 |
| Alpha | -119.49 |
| Beta | 0.94 |
| Volatility | 109.98% |
| Current Volume | 29.6k |
| Average Volume 20d | 230.1k |
What is the price of SINT stocks?
As of January 10, 2025, the stock is trading at USD 3.56 with a total of 29,604 shares traded.
Over the past week, the price has changed by -2.47%, over one month by -5.07%, over three months by +28.52% and over the past year by -95.38%.
As of January 10, 2025, the stock is trading at USD 3.56 with a total of 29,604 shares traded.
Over the past week, the price has changed by -2.47%, over one month by -5.07%, over three months by +28.52% and over the past year by -95.38%.
Is SINTX Technologies a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, SINTX Technologies is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SINT as of January 2025 is 4.22. This means that SINT is currently undervalued and has a potential upside of +18.54% (Margin of Safety).
Neither. Based on ValueRay Fundamental Analyses, SINTX Technologies is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SINT as of January 2025 is 4.22. This means that SINT is currently undervalued and has a potential upside of +18.54% (Margin of Safety).
Is SINT a buy, sell or hold?
SINTX Technologies has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold SINT.
SINTX Technologies has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold SINT.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for SINT stock price target?
According to ValueRays Forecast Model, SINT SINTX Technologies will be worth about 4.6 in January 2026. The stock is currently trading at 3.56. This means that the stock has a potential upside of +27.81%.
According to ValueRays Forecast Model, SINT SINTX Technologies will be worth about 4.6 in January 2026. The stock is currently trading at 3.56. This means that the stock has a potential upside of +27.81%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 70 | 1866.3% |
| Analysts Target Price | 7 | 96.6% |
| ValueRay Target Price | 4.6 | 27.8% |